Concepedia

Publication | Open Access

Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia

DOIFull Paper Access

114

Citations

36

References

2015

Year

Joseph M. Flynn, Jeffrey A. Jones, Amy J. Johnson, Leslie A. Andritsos, Kami J. Maddocks, Samantha Jaglowski, J Hessler, Michael R. Grever, E. Im, Haiyu Zhou,
Leukemia

References

YearCitations

Page 1